Genscript Biotech IPO - Financial Track Record Doesn't Inspire Much Confidence
Genscript Biotech (GS) plans to raise US$70-90m through its IPO. This is a follow up note to Kemp Dolliver, CFA 's insight An Intriguing Small Cap...
506 Views
An Intriguing Small Cap with Price Risk
SummaryGenscript Biotech (1548 HK) is a pending small cap healthcare IPO. We think Genscript is a very interesting company because of its leading...
426 Views